We advised our readers a few months ago of a decision by a Los Angeles Superior Court that coffee retailers in California were violating state law by not posting warnings for their customers of the presence in coffee of acrylamide, a chemical that is produced by roasting coffee beans and has been linked to cancer. Earlier this month, that same court agreed to allow some time for the California Office of Environmental Health Hazard Assessment (OEHHA) to consider whether it would grant an exemption for coffee retailers from the warning requirement. A public hearing on the OEHHA recommended exemption was held on August 16 and the public comment period closed yesterday. One of the agencies commenting in support of the exemption was the federal Food and Drug Administration (FDA). FDA Commissioner Scott Gottlieb, MD submitted formal testimony on behalf of the agency that said in part, that “[A]s a science-based agency, the FDA is committed to ensuring that information presented on a food’s label is accurate and not misleading. That’s why . . . expressing our support of this proposed regulation that would exempt coffee from a Proposition 65 cancer warning.” The FDA statement also referenced a comprehensive report by the World Health Organization’s International Agency for Research on Cancer which concluded that consuming coffee poses no significant risk of cancer.